alexa Abstract | Community-Based Infectious Disease Clinics: A Tool Of Engagement For Vulnerable Populations

Journal of Hepatitis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


Background: Hepatitis C virus (HCV) infection is a major international public health concern, particularly among people who inject drugs (PWID). The Downtown East Side of Vancouver (DTES) is known for a high prevalence of HCV infection. Despite available services, significant numbers of patients remain undiagnosed or lack access to potentially curative therapy. As such, there is a need to develop innovative means of recruitment into care and to assess the interest to seek care. Methods: Community pop-up clinics (CPCs) were held at several DTES sites (including InSite, the first supervised injection facility in North America). HCV point-of-care testing was offered. Participants were also offered the opportunity to complete a survey to collect demographic information as well as data related to their knowledge about HCV treatment and readiness to receive it. A $10 incentive was offered for participation.

Results: Since the inception of the program in March 2013, 1743 individuals have been tested, of which 1125 individuals completed the survey (implemented in January 2014), with 568 (33%) infected with HCV. About 45% were unaware of a cure for this infection, but a vast majority (over 80%) would consider HCV treatment for it, if it was offered.

Conclusions: Despite the existence of a cure for HCV infection, several barriers to HCV treatment have been identified, particularly in vulnerable populations. These barriers can exist on the levels of the patient, healthcare provider, and the health care system as a whole. There is a significant gap in HCV treatment knowledge, but a general willingness to receive care. Innovative low-threshold programs must be developed to engage those individuals in care.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Brian Conway Syune Hakobyan Sahand Vafadary Tyler Raycraft Shawn Sharma


Chronic hepatitis C, People who inject drugs, Treatment barriersc

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us